
Pevirab-LSR Capsule
Marketer
Adegen Pharma Private Limited
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Pevirab-LSR Capsule
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome are treated with the prescription medication, Lanzoprazole-SR Capsules. This medication lowers excessive stomach acid and prevents its backflow into the esophagus. Dosage and duration are determined by your physician and should be followed precisely. Treatment should continue as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and flu-like symptoms. These are typically transient. Report any concerns to your doctor immediately. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring alertness until their impact is known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. A high-fiber diet, avoidance of trigger foods, increased hydration, and regular physical activity can enhance treatment outcomes. Prior to use, disclose any kidney or liver conditions, as well as pregnancy, pregnancy planning, or breastfeeding.
Uses of Pevirab-LSR Capsule
Managing intestinal ulcers, irritable bowel syndrome, and gastroesophageal reflux disease (GERD).
Major Benefits of Pevirab-LSR Capsule:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire capsule without chewing, crushing, or fracturing it. Administer Pevirab-LSR Capsules on an empty stomach.
Common Side effects of Pevirab-LSR Capsule:
- Weakness
- Flatulence
- Vomiting
- Nausea
- Abdominal pain
- Diarrhea
- Headache
- Dizziness
- Breast enlargement in male
- Drowsiness
- Altered libido
- Absence of menstrual periods
- Unusual production of breast milk in women and men
- Cough
- Back pain
How to use Pevirab-LSR Capsule:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer Pevirab-LSR Capsules on an empty stomach.
How Pevirab-LSR Capsule works:
Levosulpiride, a gastrointestinal motility stimulant, enhances acetylcholine release, thereby boosting stomach and intestinal contractions and mitigating acid reflux. Rabeprazole, a proton pump inhibitor, diminishes gastric acid production, providing relief from acid indigestion and peptic ulcers.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pevirab-LSR Capsule and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Pevirab-LSR Capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Pevirab-LSR Capsule use while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Pevirab-LSR Capsule.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Pevirab-LSR Capsule use in individuals with renal impairment. Medical advice is recommended. Available evidence, though scant, indicates a need for prudence when prescribing this medication to such patients.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Pevirab-LSR Capsules, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Pevirab-LSR Capsule :
Should you forget a Pevirab-LSR Capsule dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pevirab-LSR Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
